• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉丁美洲人群中小肾肿瘤:特征和生存、复发及转移的预后因素——来自 LARCG 数据库的多机构研究。

Small renal masses in Latin-American population: characteristics and prognostic factors for survival, recurrence and metastasis - a multi-institutional study from LARCG database.

机构信息

A.C. Camargo Cancer Center, Rua Antônio Prudente 211, Liberdade, São Paulo, 01509-010, Brazil.

Pasteur Hospital, Montevideo, Uruguay.

出版信息

BMC Urol. 2020 Jul 2;20(1):85. doi: 10.1186/s12894-020-00649-8.

DOI:10.1186/s12894-020-00649-8
PMID:32615971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7331283/
Abstract

BACKGROUND

To evaluate demographic, clinical and pathological characteristics of small renal masses (SRM) (≤ 4 cm) in a Latin-American population provided by LARCG (Latin-American Renal Cancer Group) and analyze predictors of survival, recurrence and metastasis.

METHODS

A multi-institutional retrospective cohort study of 1523 patients submitted to surgical treatment for non-metastatic SRM from 1979 to 2016. Comparisons between radical (RN) or partial nephrectomy (PN) and young or elderly patients were performed. Kaplan-Meier curves and log-rank tests estimated 10-year overall survival. Predictors of local recurrence or metastasis were analyzed by a multivariable logistic regression model.

RESULTS

PN and RN were performed in 897 (66%) and 461 (34%) patients. A proportional increase of PN cases from 48.5% (1979-2009) to 75% (after 2009) was evidenced. Stratifying by age, elderly patients (≥ 65 years) had better 10-year OS rates when submitted to PN (83.5%), than RN (54.5%), p = 0.044. This disparity was not evidenced in younger patients. On multivariable model, bilaterality, extracapsular extension and ASA (American Society of Anesthesiologists) classification ≥3 were predictors of local recurrence. We did not identify significant predictors for distant metastasis in our series.

CONCLUSIONS

PN is performed in Latin-America in a similar proportion to developed areas and it has been increasing in the last years. Even in elderly individuals, if good functional status, sufficiently fit to surgery, and favorable tumor characteristics, they should be encouraged to perform PN. Intending to an earlier diagnosis of recurrence or distant metastasis, SRM cases with unfavorable characteristics should have a more rigorous follow-up routine.

摘要

背景

评估拉丁美洲人群中由 LARCG(拉丁美洲肾癌组)提供的小肾肿瘤(SRM)(≤4cm)的人口统计学、临床和病理特征,并分析生存、复发和转移的预测因素。

方法

对 1979 年至 2016 年间接受手术治疗的 1523 例非转移性 SRM 患者进行了多机构回顾性队列研究。对根治性肾切除术(RN)或部分肾切除术(PN)与年轻或老年患者进行了比较。Kaplan-Meier 曲线和对数秩检验估计了 10 年的总生存率。通过多变量逻辑回归模型分析局部复发或转移的预测因素。

结果

1523 例患者中,897 例(66%)行 PN,461 例(34%)行 RN。证据表明,PN 例数从 1979 年至 2009 年的 48.5%呈比例增加至 2009 年后的 75%。按年龄分层,老年(≥65 岁)患者接受 PN(83.5%)的 10 年 OS 率优于 RN(54.5%),p=0.044。在年轻患者中未发现这种差异。多变量模型显示,双侧性、包膜外延伸和 ASA(美国麻醉师协会)分级≥3 是局部复发的预测因素。在我们的研究中,没有发现远处转移的显著预测因素。

结论

PN 在拉丁美洲的开展比例与发达国家相似,近年来一直在增加。即使是老年患者,如果功能状态良好,手术适应性强,肿瘤特征有利,也应鼓励他们进行 PN。为了更早地诊断复发或远处转移,具有不利特征的 SRM 病例应进行更严格的随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c49/7331283/a7971687ffa6/12894_2020_649_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c49/7331283/3c10f4dd5add/12894_2020_649_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c49/7331283/a7971687ffa6/12894_2020_649_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c49/7331283/3c10f4dd5add/12894_2020_649_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c49/7331283/a7971687ffa6/12894_2020_649_Fig2_HTML.jpg

相似文献

1
Small renal masses in Latin-American population: characteristics and prognostic factors for survival, recurrence and metastasis - a multi-institutional study from LARCG database.拉丁美洲人群中小肾肿瘤:特征和生存、复发及转移的预后因素——来自 LARCG 数据库的多机构研究。
BMC Urol. 2020 Jul 2;20(1):85. doi: 10.1186/s12894-020-00649-8.
2
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.部分肾切除术与经皮消融术治疗 cT1 期肾肿瘤的比较。
Eur Urol. 2015 Feb;67(2):252-9. doi: 10.1016/j.eururo.2014.07.021. Epub 2014 Aug 6.
3
Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.冷冻消融与部分肾切除术治疗 T1b 期临床肾肿瘤:匹配组对比分析。
Eur Urol. 2017 Jan;71(1):111-117. doi: 10.1016/j.eururo.2016.08.039. Epub 2016 Aug 25.
4
Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.老年T1-T2期肾肿瘤行部分肾切除术与根治性肾切除术的比较:并发症、肾功能及肿瘤学结局分析
Urology. 2017 Feb;100:151-157. doi: 10.1016/j.urology.2016.10.047. Epub 2016 Nov 23.
5
Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.cT1-2/N0/M0期透明细胞肾细胞癌行微创部分肾切除术与微创根治性肾切除术的肿瘤学结局:一项倾向评分匹配分析
World J Urol. 2017 May;35(5):789-794. doi: 10.1007/s00345-016-1923-2. Epub 2016 Aug 30.
6
Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.部分肾切除术与根治性肾切除术相比,在老年 Ib-II 期肾肿块患者中并不具有总体生存优势:国家癌症数据库分析。
Cancer. 2018 Oct 1;124(19):3839-3848. doi: 10.1002/cncr.31582. Epub 2018 Sep 12.
7
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.保肾手术后切缘阳性预测肾细胞癌无复发生存:单中心 459 例病例队列的 5 年以上随访结果。
Clin Genitourin Cancer. 2019 Feb;17(1):e26-e31. doi: 10.1016/j.clgc.2018.08.004. Epub 2018 Aug 23.
8
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.部分肾切除术与根治性肾切除术治疗 T1b 和 T2 期临床肾肿瘤的比较:系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7.
9
Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?临床 T1N0M0 期肾细胞癌行部分肾切除术的患者,最终病理出现非器官局限性疾病是否会破坏其肿瘤控制?
Eur Urol Focus. 2018 Dec;4(6):972-977. doi: 10.1016/j.euf.2017.02.020. Epub 2017 Mar 21.
10
Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.cT2a期肾肿瘤行部分肾切除术和根治性肾切除术后的总生存期及肿瘤学结局:法国肾癌研究网络UroCCR的一项国际合作研究
Prog Urol. 2018 Mar;28(3):146-155. doi: 10.1016/j.purol.2017.12.004. Epub 2018 Jan 11.

引用本文的文献

1
Histopathological and immunohistochemical characteristics of adult renal tumors: a five-year retrospective study in Mureş County, Romania.罗马尼亚穆列什县成人肾脏肿瘤的组织病理学和免疫组织化学特征:一项为期五年的回顾性研究。
Rom J Morphol Embryol. 2024 Jul-Sep;65(3):457-465. doi: 10.47162/RJME.65.3.08.

本文引用的文献

1
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis.
年龄对小肾肿块患者癌症特异性死亡率的影响:一项基于人群的分析。
Can Urol Assoc J. 2018 Jul;12(7):E325-E330. doi: 10.5489/cuaj.4854. Epub 2018 Mar 19.
4
Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries.肾癌的发病率和死亡率:39 个国家的时间模式和全球趋势。
Sci Rep. 2017 Nov 16;7(1):15698. doi: 10.1038/s41598-017-15922-4.
5
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT non-metastatic renal cell carcinoma treated with radical nephrectomy.淋巴结清扫和阳性淋巴结对接受根治性肾切除术治疗的当代pT期非转移性肾细胞癌患者癌症特异性死亡率的影响。
BJU Int. 2018 Mar;121(3):383-392. doi: 10.1111/bju.14024. Epub 2017 Oct 12.
6
Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.临床局限性肾肿块的部分肾切除术与根治性肾切除术对比
Cochrane Database Syst Rev. 2017 May 9;5(5):CD012045. doi: 10.1002/14651858.CD012045.pub2.
7
The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols.肾肿瘤的转移潜能:组织学亚型对小肾肿块定义、风险分层及未来主动监测方案的影响。
Urol Oncol. 2017 Apr;35(4):153.e15-153.e20. doi: 10.1016/j.urolonc.2016.11.009. Epub 2017 Feb 12.
8
The creation, development and diffusion of the LARCG latin american renal cancer group.拉丁美洲肾癌研究小组(LARCG)的创立、发展与传播
Int Braz J Urol. 2017 Jan-Feb;43(1):3-6. doi: 10.1590/S1677-5538.IBJU.2017.01.02.
9
American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy.美国泌尿外科学会(CAU)在微创部分肾切除术方面的经验。
World J Urol. 2017 Jan;35(1):57-65. doi: 10.1007/s00345-016-1837-z. Epub 2016 Apr 30.
10
Surgical treatment of renal-cell carcinoma in elderly people.老年人肾细胞癌的外科治疗
Actas Urol Esp. 2016 Jul-Aug;40(6):395-9. doi: 10.1016/j.acuro.2016.01.009. Epub 2016 Mar 8.